ES3035981T3 - Long-term stable live microbiota composition - Google Patents

Long-term stable live microbiota composition

Info

Publication number
ES3035981T3
ES3035981T3 ES20716843T ES20716843T ES3035981T3 ES 3035981 T3 ES3035981 T3 ES 3035981T3 ES 20716843 T ES20716843 T ES 20716843T ES 20716843 T ES20716843 T ES 20716843T ES 3035981 T3 ES3035981 T3 ES 3035981T3
Authority
ES
Spain
Prior art keywords
water
composition
cellulose
excipients
fecal microbiota
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES20716843T
Other languages
English (en)
Spanish (es)
Inventor
Negre Josep M Sune
Viladomiu Alex Soriano
Gomez Andrea Aira
Csaba Feher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitat de Barcelona UB
Hospital Clinic de Barcelona
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Original Assignee
Universitat de Barcelona UB
Hospital Clinic de Barcelona
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitat de Barcelona UB, Hospital Clinic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer filed Critical Universitat de Barcelona UB
Application granted granted Critical
Publication of ES3035981T3 publication Critical patent/ES3035981T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4875Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES20716843T 2019-04-15 2020-04-14 Long-term stable live microbiota composition Active ES3035981T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19382287 2019-04-15
PCT/EP2020/060370 WO2020212297A1 (en) 2019-04-15 2020-04-14 Long-term stable live fecal microbiota composition

Publications (1)

Publication Number Publication Date
ES3035981T3 true ES3035981T3 (en) 2025-09-11

Family

ID=66349477

Family Applications (1)

Application Number Title Priority Date Filing Date
ES20716843T Active ES3035981T3 (en) 2019-04-15 2020-04-14 Long-term stable live microbiota composition

Country Status (19)

Country Link
US (2) US20220143107A1 (https=)
EP (2) EP3955899B1 (https=)
JP (1) JP2022529008A (https=)
KR (1) KR20210152505A (https=)
CN (1) CN113710237B (https=)
AU (1) AU2020259740B2 (https=)
BR (1) BR112021020606A2 (https=)
CA (1) CA3130816A1 (https=)
DK (1) DK3955899T3 (https=)
EA (1) EA202192291A1 (https=)
ES (1) ES3035981T3 (https=)
FI (1) FI3955899T3 (https=)
IL (1) IL287238A (https=)
MX (1) MX2021011246A (https=)
PH (1) PH12021552573A1 (https=)
PL (1) PL3955899T3 (https=)
PT (1) PT3955899T (https=)
SG (1) SG11202110641XA (https=)
WO (1) WO2020212297A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017024265B1 (pt) 2015-05-11 2022-08-09 Mybiotics Pharma Ltd Métodos para crescimento de um biofilme de bactérias probióticas em partículas sólidas
IL294171A (en) 2016-05-25 2022-08-01 Mybiotics Pharma Ltd Composition and methods for microbiota therapy
EP3955899B1 (en) 2019-04-15 2025-05-07 Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS) Long-term stable live microbiota composition

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1190386A (en) * 1966-06-28 1970-05-06 Green Cross Corp Process for producing the Lactic Acid Bacteria Drugs
FR2708621B1 (fr) * 1993-07-29 1995-10-20 Lesaffre & Cie Biomasse stable à base de cellules de levure et de bactéries lactiques et procédé de préparation.
ITMI20011632A1 (it) 2001-07-27 2003-01-27 Sanofi Synthelabo Composizione solida contenente spore di batteri non patogeni del genere bacillus
US20050266069A1 (en) 2002-09-06 2005-12-01 Simmons Donald L Stable probiotic microsphere compositions and their methods of preparation
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
GB0330009D0 (en) * 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
CA2623968C (en) 2005-09-29 2014-12-09 Merck Patent Gesellschaft Mit Beschraenkter Haftung Method for stabilising pharmaceutical administration forms comprising microorganisms
DE102005062731A1 (de) * 2005-12-22 2007-06-28 Organobalance Gmbh Neue Lactobacillus Stämme und deren Verwendung
TR200800634A2 (tr) * 2008-01-30 2009-02-23 Takka Sevgi̇ Uzatılmış salım sağlayan fluvastatin tablet.
CA2808610C (en) * 2010-08-10 2018-09-25 R.P. Scherer Technologies, Llc Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria
CN104095180A (zh) * 2013-04-12 2014-10-15 中国科学院烟台海岸带研究所 一种益生菌菊粉片及其制备方法
US10583420B2 (en) * 2014-10-01 2020-03-10 7905122 Canada Inc. Process and apparatus for manufacturing water-absorbing material and use in cat litter
WO2016178775A1 (en) * 2015-05-01 2016-11-10 Microbiome Health Research Institute Inc. Compositions and methods for therapeutic delivery of microbial communities
CN104922158B (zh) * 2015-06-05 2018-11-02 中国人民解放军第三军医大学第三附属医院 粪菌胶囊及其制备与应用
US10905726B2 (en) 2015-06-09 2021-02-02 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
CN109414048B (zh) * 2016-06-30 2023-09-01 弗门尼舍有限公司 包衣酵母配方
US20200147151A1 (en) * 2017-01-30 2020-05-14 The Board Of Regents Of The University Of Texas System Compositions and methods for fecal microbiota transplantation
US20200188310A1 (en) 2017-08-29 2020-06-18 Chr. Hansen A/S Stable capsules with fecal microbiota or a culture of microorganisms
CN108567799A (zh) * 2018-08-01 2018-09-25 中国人民解放军总医院 一种全粪菌复合胶囊及其制备方法和应用
EP3955899B1 (en) 2019-04-15 2025-05-07 Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS) Long-term stable live microbiota composition

Also Published As

Publication number Publication date
KR20210152505A (ko) 2021-12-15
EP4609873A2 (en) 2025-09-03
EP3955899B1 (en) 2025-05-07
PT3955899T (pt) 2025-07-18
EA202192291A1 (ru) 2022-02-11
DK3955899T3 (da) 2025-08-04
BR112021020606A2 (pt) 2021-12-07
AU2020259740B2 (en) 2025-12-18
AU2020259740A1 (en) 2021-10-28
MX2021011246A (es) 2022-01-18
IL287238A (en) 2021-12-01
SG11202110641XA (en) 2021-10-28
JP2022529008A (ja) 2022-06-16
EP4609873A3 (en) 2025-11-12
CN113710237A (zh) 2021-11-26
CN113710237B (zh) 2026-04-03
WO2020212297A1 (en) 2020-10-22
EP3955899A1 (en) 2022-02-23
PH12021552573A1 (en) 2022-07-04
US20240131085A1 (en) 2024-04-25
FI3955899T3 (fi) 2025-07-28
US12521422B2 (en) 2026-01-13
PL3955899T3 (pl) 2025-09-22
CA3130816A1 (en) 2020-10-22
US20220143107A1 (en) 2022-05-12

Similar Documents

Publication Publication Date Title
US12521422B2 (en) Long-term stable live fecal microbiota composition
ES2426258T3 (es) Composiciones farmacéuticas que comprenden bacterias que reducen oxalato
US12016880B2 (en) Halogen treatment of heart attack and ischemic injury
US8324175B2 (en) Compositions and methods for the treatment of cancer
ES2801801T3 (es) Composición farmacéutica
US20080145448A1 (en) Calcium Potassium Ferrocyanide, a Prophylactic Mixture Comprising this Compound and the Use Thereof for Decorporation of Radiocesium in Subjects Affected by Nuclear Radiation
CN108472321A (zh) 用于保存在生态系统中的微生物群的冻干组合物
CN116725979B (zh) 一种胃肠道微环境响应型纳米涂层包覆益生菌的制备方法及其应用
JP2020526583A5 (https=)
JP2012514629A (ja) 経口送達のための生細胞の配合物
CA3009332A1 (en) Pharmaceutical formulations for treating kidney stones and methods for fabricating and using thereof
HK40068341A (en) Long‑term stable live microbiota composition
HK40068341B (en) Long‑term stable live microbiota composition
CZ2014580A3 (cs) Doplněk stravy na bázi klikvy velkoplodé pro použití k oddálení biochemického návratu karcinomu prostaty
NL2034600B1 (en) Rectal administration of carglumic acid
KR102820861B1 (ko) 유산균 저장 안정성 증강용 조성물 및 이를 이용한 저장 안정성 개선방법
RU2147438C1 (ru) Способ стабилизации растворенного состояния и антибактериальной активности пектина
FR3097740A1 (fr) Bactérie de la famille des Christensenellacées et composition en contenant pour la prévention et/ou le traitement d’une perte de masse musculaire pathologique ou d’une maladie caractérisée par une perte de masse musculaire pathologique
US20240269165A1 (en) Fine silicon particle-containing preventive or therapeutic agent for diseases
JP2018536701A (ja) 炎症性腸疾患の治療用のチラコイド抽出組成物及び製剤
AU2024272393A1 (en) Production of a pharmaceutical dosage form from horseradish and nasturtium
WO2024164391A1 (zh) 猪丹毒活疫苗的耐热保护剂及其制备方法和应用
RU2351345C1 (ru) Способ получения средства для лечения диареи у сельскохозяйственных животных, средство для лечения диареи у сельскохозяйственных животных и способ лечения диареи
RU2327465C1 (ru) Способ лечения дизентерии у поросят
BG4023U1 (bg) Стабилизирана таблетка, съдържаща витаминен комплекс